Tag Archives: RFA Ticker

RFA Ticker, 12/12/16

Posted on December 12, 2016 by Jennie Spotila

It’s December and the news we’ve all been waiting for – the announcement of ME/CFS RFAs – has not come. But other things of note have been happening. On the RFA front, NIH has passed half a billion dollars in … Continue reading →

Posted in Advocacy, Research | Tagged , , , , , , , , , , , , , , | 9 Comments

RFA Ticker, 12/5/16

Posted on December 5, 2016 by Jennie Spotila

The news in the past week was more about NIH generally, rather than ME specifically. President-elect Trump has nominated Representative Tom Price to be Secretary of HHS. This has touched off a war of words within the medical community, as … Continue reading →

Posted in Advocacy, Research | Tagged , , , , , , , , , , , , , | 6 Comments

RFA Ticker, 11/28/16

Posted on November 28, 2016 by Jennie Spotila

A short week due to the Thanksgiving holiday doesn’t slow NIH down, apparently. More than $40 million was committed to RFAs last week. ME/CFS research didn’t even get the giblets. Will we be more successful in December? Here are the … Continue reading →

Posted in Advocacy, Research | Tagged , , , , , , , , , , , , | 4 Comments

RFA Ticker, 11/21/16

Posted on November 21, 2016 by Jennie Spotila

The big news (apart from the election, of course) is that Carol Head and Dr. Zaher Nahle of the Solve ME/CFS Initiative had a brief meeting with Dr. Francis Collins, Director of NIH. SMCI reported: Dr. Collins could not offer … Continue reading →

Posted in Advocacy, Research | Tagged , , , , , , , , , , , , , | 7 Comments

RFA Ticker, 11/14/16

Posted on November 14, 2016 by Jennie Spotila

It got a bit crazy with NIH last week, didn’t it? The talk by Dr. Shorter went ahead as scheduled on November 9th, much to the chagrin of the entire patient community. Afterwards, NIH issued a follow up response which … Continue reading →

Posted in Advocacy, Research | Tagged , , , , , , , , , , , , , | 12 Comments

RFA Ticker, 11/7/16

Posted on November 7, 2016 by Jennie Spotila

We learned a bit more about NIH’s plans for ME/CFS RFAs during last week’s NIH telebriefing. In response to a comment from Bob Miller, Dr. Koroshetz said that funding for the research consortia centers will be “significant” and “equivalent to … Continue reading →

Posted in Advocacy, Research | Tagged , , , , , , , , , , , , , | 4 Comments

RFA Ticker, 10/31/16

Posted on October 31, 2016 by Jennie Spotila

Among the $53 million in RFAs issued by NIH last week were two RFAs for pilot clinical trials in pediatric chronic kidney disease. These are significant for us because the RFAs establish a network of three participating clinical centers and … Continue reading →

Posted in Advocacy, Research | Tagged , , , , , , , , , , , , , | 5 Comments

RFA Ticker, 10/24/16

Posted on October 24, 2016 by Jennie Spotila

Another huge week for RFAs at NIH! Last week alone, NIH issued 17 RFAs for a total of more than $94 million. ME/CFS research did not get an RFA, but we did get official news about the RFAs promised us … Continue reading →

Posted in Advocacy, Research | Tagged , , , , , , , , , , , , , | 9 Comments

RFA Ticker, 10/17/16

Posted on October 17, 2016 by Jennie Spotila

Have you heard the expression “Go big or go home?” That is the perfect description of last week’s RFA totals. NIH only issued one RFA last week, but it was a big one. The set aside funding of $28,750,000 more … Continue reading →

Posted in Advocacy, Research | Tagged , , , , , , , , , , , , , | 8 Comments

RFA Ticker, 10/10/16

Posted on October 10, 2016 by Jennie Spotila

It’s a new year (in Washington DC, anyway). I didn’t have to turn the RFA Ticker back to zero, since that is where it was all of FY 2016. But here we are, so let’s get started on FY 2017. … Continue reading →

Posted in Advocacy, Research | Tagged , , , , , , , , , , , , | 6 Comments